Erratum Regarding "Managing Hyperkalemia to Enable Guideline-Recommended Dosing of Renin-Angiotensin-Aldosterone System Inhibitors" (Am J Kidney Dis. 2022;80[2]:159-160)
- PMID: 36273832
- DOI: 10.1053/j.ajkd.2022.09.001
Erratum Regarding "Managing Hyperkalemia to Enable Guideline-Recommended Dosing of Renin-Angiotensin-Aldosterone System Inhibitors" (Am J Kidney Dis. 2022;80[2]:159-160)
Erratum for
-
Managing Hyperkalemia to Enable Guideline-Recommended Dosing of Renin-Angiotensin-Aldosterone System Inhibitors.Am J Kidney Dis. 2022 Aug;80(2):158-160. doi: 10.1053/j.ajkd.2022.02.012. Epub 2022 Apr 21. Am J Kidney Dis. 2022. PMID: 35461743 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
